Paxlovid reduces progression to severe COVID19 by 89% of mild cases.
Paxlovid reduces progression to severe COVID19 by 89% of mild cases. Paxlovid contains nirmaltrevir (inhibits peptidomimetic inhibitor to reduce viral replication and ritonavir (inhibits CYP mediated metabolism of niramaltrevir; science!). The numbers say that Paxlovid is pretty good is treating mild cases of COVID, but keep several things in mind. Theres several drug to drug interactions; have a pharmacist do an interaction report. The common side effects include change in taste and diarrhea, while hepatotoxicity can occur in rare cases. There also been reports of rebound COVID with Paxlovid, meaning a return of symptoms after completing a course. The PHARMFAX are running hot, share one of my videos with a friend. Visit my website www.pharmwyze.com References can also be found here. #paxlovid #medicine #pharmacy #covid #pharmwyze #nursing Not medical advice. Educational purposes only. No relationships to report. I hope you learned something new.
Comments